WinstonWınston
Back
Humana logo

Humana

HUM
24
Medical - Healthcare Plans · Healthcare
Also trades as: 0J6Z.L · 0RF7.L · HUM.ST
Winston Score
24
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Good
Dividends
Weak

Winston Score History

The full picture

Humana is one of the largest health insurance companies in the United States. It sells health insurance plans to individuals, employers, and government programs. Its biggest business is Medicare Advantage, which are private health plans sold to Americans aged 65 and older — Humana is one of the top two providers of these plans in the country.

Humana makes most of its money by collecting monthly premiums from members and then paying their medical bills. It operates almost entirely in the United States and covers roughly 17 million members across its various plans. Its large Medicare Advantage membership base gives it scale and brand recognition with older Americans, but the company faces serious pressure when medical costs rise faster than the premiums it collects — a dynamic that has squeezed its margins recently and is the central risk investors are watching closely.

Politician Trades

24 trades / 12mo

10 Congressional buys and 14 sells on HUM in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+26.2% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+28.1% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

0.2%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

5+ years

Quarterly Free Cash Flow

↑ Burn rate improving

$24.5B cash & investments at current burn rate

Revenue accelerating

Humana grew revenue 26% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.5%
Thin — 13.5% gross margin
Profit after running costs
Operating Margin
3.3%
Thin — 3.3% operating margin
Return on the money invested
ROCE
6.0%
Weak — 6.0% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+18.3%
Fast-growing sales (+18.3% YoY)
Profit growth
EPS YoY
-18.5%
Earnings shrinking (-18.5% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
12%
Weak — only 12% of profit becomes cash
Spare cash per sale
FCF Margin
-0.3%
Burning cash (-0.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.74
Moderate — manageable debt (0.74)
Covers its interest
Interest Cover
2.87x
Tight — interest eats into profit (2.9x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
35.6x
no trend
Pricey — P/E 35.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+21.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (35.6 → 13.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.93%
no trend
Small dividend — 0.93% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial